JW (Cayman) Therapeutics Co. Ltd (2126.HK)
HKD 1.45
(2.11%)
HKD 1.45
(2.11%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.14 Billion CNY | -23.12% |
| 2022 | 2.79 Billion CNY | -10.44% |
| 2021 | 3.11 Billion CNY | -17.54% |
| 2020 | 3.77 Billion CNY | 465.27% |
| 2019 | 668.61 Million CNY | 96.18% |
| 2018 | 340.82 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.97 Billion CNY | 0.0% |
| 2023 Q2 | 2.86 Billion CNY | 0.0% |
| 2023 Q4 | 2.14 Billion CNY | 0.0% |
| 2023 FY | 2.14 Billion CNY | -23.12% |
| 2022 FY | 2.79 Billion CNY | -10.44% |
| 2022 Q4 | 3.13 Billion CNY | 0.0% |
| 2022 Q2 | 3.39 Billion CNY | 0.0% |
| 2021 Q4 | 3.81 Billion CNY | 0.0% |
| 2021 Q2 | 4.18 Billion CNY | 0.0% |
| 2021 FY | 3.11 Billion CNY | -17.54% |
| 2020 FY | 3.77 Billion CNY | 465.27% |
| 2020 Q4 | 4.48 Billion CNY | 0.0% |
| 2020 Q2 | 2.21 Billion CNY | 0.0% |
| 2019 Q4 | 747.91 Million CNY | 0.0% |
| 2019 FY | 668.61 Million CNY | 96.18% |
| 2019 Q2 | - HKD | 0.0% |
| 2018 FY | 340.82 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 409.99 Million HKD | -423.449% |
| CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 80.919% |